Maintenance Trial by Orencia in Rheumatoid Arthritis
Not Applicable
- Conditions
- Rheumatoid Arthritis
- Registration Number
- JPRN-UMIN000010286
- Lead Sponsor
- Hokkaido University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients contraindicated with abatacept 2. Patients more than 125 kg in weight 3. Patients considered ineligible for this study for any reason by the attending physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Continuance rate of patients receiving a reduced dose of abatacept after 1 year
- Secondary Outcome Measures
Name Time Method 1.SDAI,CDAI,DAS28 at 1 year 2.TSS at 1 year 3.HAQ-DI at 1 year 4.Joint Ultrasonography at 1 year